TRANSPEK vs VITAL: Stock Comparison
TRANSPEK shows a lower P/E, a higher dividend yield and lower leverage, while VITAL CHEMTECH shows a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
TRANSPEK leads 8; VITAL leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | TRANSPEK | VITAL |
|---|---|---|
| Live Price | ₹1,232.6 | ₹55.4 |
| Day Change | -2.36% | 0.38% |
| Volume | 5,657 | 4,769 |
| 52-Week High | ₹1,447.9 | ₹69.4 |
| 52-Week Low | ₹952.3 | ₹35.4 |
| Distance from 52W High | -14.87% | -20.17% |
Valuation
| Metric | TRANSPEK | VITAL |
|---|---|---|
| Market Cap | ₹760 Cr | — |
| P/E Ratio | 15.66x | 32.07x |
| P/B Ratio | 0.8x | 1.4x |
| EPS | ₹15.98 | ₹0.88 |
| Book Value | ₹1,373.97 | ₹41.74 |
| Dividend Yield | 1.47% | 0% |
Growth
| Metric | TRANSPEK | VITAL |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 0% | -14.67% |
| Qtr Profit Growth | 0% | -18.32% |
Profitability & Leverage
| Metric | TRANSPEK | VITAL |
|---|---|---|
| ROE | 5.95% | 7.95% |
| ROCE | 6.87% | 8.3% |
| Net Margin | 7.35% | 0.81% |
| Operating Margin | 11.15% | 11.38% |
| Debt to Equity | 0.06x | 0.1x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | TRANSPEK | VITAL |
|---|---|---|
| Promoter Holding | 57.27% | 73.43% |
| FII Holding | 0.02% | 1.62% |
| DII Holding | 1.05%▼ 0.55 pp | 0.25% |
| Public Holding | 41.66%▲ 0.75 pp | 24.7% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: TRANSPEK and VITAL CHEMTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.